[go: up one dir, main page]

AR033096A1 - Acomposicion antifungal con aumentada biodisponibilidad - Google Patents

Acomposicion antifungal con aumentada biodisponibilidad

Info

Publication number
AR033096A1
AR033096A1 ARP020101198A ARP020101198A AR033096A1 AR 033096 A1 AR033096 A1 AR 033096A1 AR P020101198 A ARP020101198 A AR P020101198A AR P020101198 A ARP020101198 A AR P020101198A AR 033096 A1 AR033096 A1 AR 033096A1
Authority
AR
Argentina
Prior art keywords
accomposition
biodisponibility
antifungal
increased
pharmaceutically acceptable
Prior art date
Application number
ARP020101198A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR033096(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR033096A1 publication Critical patent/AR033096A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe una suspension líquida que comprende una cantidad antifungal eficaz del compuesto micronizado representado por la formula estructural química (1), por lo menos un agente espesador, un surfactante no ionico y un portador líquido farmacéuticamente aceptable.
ARP020101198A 2001-04-03 2002-04-02 Acomposicion antifungal con aumentada biodisponibilidad AR033096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28113901P 2001-04-03 2001-04-03

Publications (1)

Publication Number Publication Date
AR033096A1 true AR033096A1 (es) 2003-12-03

Family

ID=23076102

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101198A AR033096A1 (es) 2001-04-03 2002-04-02 Acomposicion antifungal con aumentada biodisponibilidad

Country Status (18)

Country Link
US (2) US20030055067A1 (es)
EP (2) EP2090165A3 (es)
JP (2) JP4308902B2 (es)
KR (1) KR100607742B1 (es)
CN (1) CN100415234C (es)
AR (1) AR033096A1 (es)
AU (1) AU2002257104B2 (es)
BR (1) BR0208626A (es)
CA (1) CA2443089C (es)
HU (1) HUP0400856A3 (es)
MX (1) MXPA03009021A (es)
NO (1) NO20034419L (es)
NZ (1) NZ528363A (es)
PE (1) PE20020994A1 (es)
PL (1) PL212985B1 (es)
TW (1) TWI311464B (es)
WO (1) WO2002080678A1 (es)
ZA (1) ZA200307684B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
EP1761247A1 (en) * 2004-05-28 2007-03-14 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
SG170047A1 (en) 2006-05-30 2011-04-29 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations
AR061351A1 (es) 2006-06-14 2008-08-20 Intervet Int Bv Composicion de carbamato de bencimidazol
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
JP2011516613A (ja) * 2008-04-15 2011-05-26 シェーリング コーポレイション 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
CN102065842A (zh) * 2008-04-15 2011-05-18 先灵公司 优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US20120101277A1 (en) 2009-07-09 2012-04-26 Sandoz Ag Crystalline form of posaconazole
EP2571869B1 (en) 2010-05-19 2015-09-23 Sandoz AG Purification of posaconazole and posaconazole intermediates
EP2571871B1 (en) 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
CN102892762B (zh) 2010-05-19 2016-04-20 桑多斯股份公司 制备泊沙康唑中间体
CN102892750B (zh) 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
CN104379132A (zh) 2012-06-14 2015-02-25 桑多斯股份公司 包含结晶泊沙康唑的药物组合物
EA033736B1 (ru) 2014-12-05 2019-11-20 Pulmocide Ltd Антимикотическое соединение
CN107635988B (zh) * 2015-05-21 2021-06-18 普尔莫赛德有限公司 抗真菌的苯甲酰胺类衍生物或其可药用盐
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
EA038421B1 (ru) * 2015-12-30 2021-08-26 ВиПиЭс-3, ИНК. Соединения, ингибирующие металлоферменты
CN106389390A (zh) * 2016-06-30 2017-02-15 重庆华邦制药有限公司 泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
WO2021229359A2 (en) * 2020-05-12 2021-11-18 Cellix Bio Private Limited Process for the preparation salts of triazole compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5552160A (en) 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
AU642066B2 (en) 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5661151A (en) 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
JP2834889B2 (ja) 1993-12-21 1998-12-14 シェーリング コーポレイション テトラヒドロフラン抗真菌剤
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
EP0862917A4 (en) * 1995-11-20 2002-01-09 Banyu Pharma Co Ltd ANTIFUNGAL COMPOSITION
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
WO1998051281A1 (en) * 1997-05-14 1998-11-19 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
WO1999061001A1 (en) 1998-05-29 1999-12-02 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Also Published As

Publication number Publication date
US20030055067A1 (en) 2003-03-20
HUP0400856A2 (hu) 2004-08-30
CN100415234C (zh) 2008-09-03
KR100607742B1 (ko) 2006-08-01
CN1499930A (zh) 2004-05-26
AU2002257104B2 (en) 2006-02-09
WO2002080678A1 (en) 2002-10-17
NO20034419L (no) 2003-12-02
US20110244004A1 (en) 2011-10-06
EP1372394A1 (en) 2004-01-02
HUP0400856A3 (en) 2012-09-28
CA2443089C (en) 2011-11-01
MXPA03009021A (es) 2004-02-12
PL363965A1 (en) 2004-11-29
EP2090165A3 (en) 2012-03-28
NZ528363A (en) 2005-04-29
PE20020994A1 (es) 2002-11-01
BR0208626A (pt) 2004-03-09
TWI311464B (en) 2009-07-01
PL212985B1 (pl) 2012-12-31
JP4308902B2 (ja) 2009-08-05
JP2008120836A (ja) 2008-05-29
CA2443089A1 (en) 2002-10-17
JP2004527525A (ja) 2004-09-09
KR20030087052A (ko) 2003-11-12
US8263600B2 (en) 2012-09-11
EP2090165A2 (en) 2009-08-19
NO20034419D0 (no) 2003-10-02
ZA200307684B (en) 2005-03-30

Similar Documents

Publication Publication Date Title
AR033096A1 (es) Acomposicion antifungal con aumentada biodisponibilidad
AU2002310156A1 (en) 1,4-disubstituted benzo-fused cycloalkyl urea compounds
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
MX9305277A (es) Monohidrato de 5-(2-4(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-dihidro-2h-indol-2-1-clorhidrato.
AR002932A1 (es) Solucion acuosa de interferon
CL2008002673A1 (es) Procedimiento se preparacion de citalopram que comprende hacer reaccionar un compuesto derivado de benzofurano con un agente eshidratante y una sulfonamida (div. sol. 2003-01).
EP1401433A4 (en) CONSTANTLY CONFORMING ANALOGUES AS AGENTS AGAINST DIABETES AND AGAINST OBESITY, AND ASSOCIATED METHOD
BR9916772A (pt) Quinolinacarboxamidas como agentes antivirais
DE69600431D1 (de) Kombination einer antimikrobiellen Verbindung (z.B. der Lipoaminosäure N,n-Octanoyl-glycin) und eines Monoalkylglycerinethers und ihre Verwendung als antimikrobieller Wirkstoff
BR9916132A (pt) Composições e utilização das mesmas
ES2095884T3 (es) Agente antiviral.
EP1385515A4 (en) SPIROPYRAZOLE COMPOUNDS
DE59509881D1 (de) Thixotrope wässrige Pflanzenschutzmittel-Suspension
ES2080586T3 (es) Composiciones detergentes.
ATE285174T1 (de) Neuartige verbindungen
MY120864A (en) Composition for preventing creeping of a flux for soldering and use thereof.
ATE7799T1 (de) Bleich- und reinigungsmittelzusammensetzungen.
ES2165028T3 (es) Geles de limpieza.
ATE396743T1 (de) Stabile elektrolytlösungen enthaltend taurolidin
ATE150036T1 (de) Ziegler-natta-katalysatorsysteme mit speziellen siliciumorganischen verbindungen
AR025189A1 (es) Tampon y proceso para su fabricacion
BR0012751A (pt) Benzofuranos serotonérgicos
EA200100364A1 (ru) Тиазолилциннамонитрилы и средства борьбы с вредителями
ES2111768T3 (es) Derivados de carboestirilo utilizados como agentes antiarritmicos.
LT2003100A (en) S-omeprazole inclusion complex with cyclodextrins

Legal Events

Date Code Title Description
FC Refusal